Withaferin A, an oxidative cytotoxic agent, resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through AKT/mTOR pathway inhibitory modulation [57]. Here, AKT1 is linked to glioblastoma.